Neuropeptide cyclo-L-prolylglycine counteracts scopolamine-induced long-term memory impairment in rats in the novel object recognition test
Background. Cyclo-L-prolylglycine (CPG) was designed and synthesized at the V.V. Zakusov as a topological analogue of the classical nootrop piracetam and was further identified as an endogenous compound. Previously, the nootropic effect of CPG was revealed in a model of retrograde amnesia in rats indu...
Saved in:
Main Authors: | O. N. Vorontsova, A. G. Alyaeva, K. N. Koliasnikova, E. A. Valdman, P. Yu. Povarnina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC “Publisher OKI”
2023-11-01
|
Series: | Фармакокинетика и Фармакодинамика |
Subjects: | |
Online Access: | https://www.pharmacokinetica.ru/jour/article/view/381 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Involvement of TRK receptors in the nootropic effect of cycloprolylglycine
by: O. N. Vorontsova, et al.
Published: (2025-01-01) -
Pharmacokinetics and neurotropic effects of cyclo-L-prolylglycine and its modified analogues
by: S. S. Boyko, et al.
Published: (2022-01-01) -
Successful treatment of enterocutaneous fistula after esophagectomy with scopolamine ointment and negative pressure wound therapy: a case report
by: Shigemasa Suzuki, et al.
Published: (2020-07-01) -
Ambroxol confers neuroprotection against scopolamine-induced Alzheimer’s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways
by: Waqas Ahmad, et al.
Published: (2025-07-01) -
Transient epileptic amnesia versus transient global amnesia: aspects of differential diagnosis
by: L. V. Lipatova, et al.
Published: (2024-07-01)